Finally, the PD-L1 expression and MSI status of most of the patients enrolled were unknown, so we cannot draw any conclusions on the correlation between MSI status, PD-L1 expression and response/survival in advanced CCA patients. This evidence concerns the gene CD274 and cholangiocarcinoma.